Lazard Asset Management »

Lenz Therapeutics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $0 12 0.00
2024-03-31 $0 288 0.00

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Alphabet Inc A Common Stock (GOOGL)
Apple Common Stock (AAPL)
Visa Common Stock (V)
Norfolk Souther Common Stock (NSC)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Accenture Common Stock (ACN)
Applied Matls I Common Stock (AMAT)
Bank Of America Common Stock (BAC)
Nvidia Corp Common Stock (NVDA)
Broadcom Common Stock (AVGO)
Thermo Fisher Common Stock (TMO)
Aon Plc/ireland Common Stock (AON)

View all positions for Lazard Asset Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
Point72 Asset Management
Tang Capital Management
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Ikarian Capital
Board of Trustees of The Leland Stanford Junior University
Wealth Enhancement Advisory Services

View all funds holding Lenz Therapeutics